Mohr R, Brenig C, Raftery B
Klin Wochenschr. 1983 Oct 3;61(19):955-62. doi: 10.1007/BF01550268.
The idiotype is a product of malignant plasmacells and can be identified in a highly specific manner by antiidiotypic antisera. The idiotype is usefull as a tumor-specific marker in myelomas and has been worked with in different problems. The main methods used were: immunofluorescence, internal labeling of immunoglobulins with radioactive-labeled aminoacids, radio-immunobinding-inhibition assay. The results are as follows: 1. Idiotype bearing precursor-cells are detectable in the periphery of myeloma patients. But in our experimental approach we were not able to demonstrate, that these cells are in fact synthesizing the idiotype although the methode has been proved to be sensitive enough. 2. The idiotypic proportion of the total immunoglobulin-fraction (= M-component in the electrophorisis) in myelomasera ranges between 40 and 90%. This percentage remains in the order of 40% even in complete remission. 3. The idiotype as tumorspecific marker is only usefull as an early detector of relapse in patients with complete remission.
独特型是恶性浆细胞的产物,可通过抗独特型抗血清以高度特异性的方式进行鉴定。独特型作为骨髓瘤中的肿瘤特异性标志物很有用,并已应用于不同问题的研究。使用的主要方法有:免疫荧光法、用放射性标记氨基酸对免疫球蛋白进行内部标记、放射免疫结合抑制试验。结果如下:1. 在骨髓瘤患者外周血中可检测到携带独特型的前体细胞。但在我们的实验方法中,尽管该方法已被证明足够灵敏,但我们无法证明这些细胞实际上正在合成独特型。2. 骨髓瘤血清中总免疫球蛋白组分(=电泳中的M成分)的独特型比例在40%至90%之间。即使在完全缓解期,该百分比仍保持在40%左右。3. 独特型作为肿瘤特异性标志物仅在完全缓解患者复发的早期检测中有用。